Duality of angiotensin receptors and opposite link between angiotensin II and stroke risk in patients with and without coronary disease: A hypothesis

被引：0
|
作者：
Fournier, A
Mazouz, H
Achard, JM
Choukroun, G
Boissel, JP
机构：
[1] CHU Amiens, Dept Nephrol, Amiens, France
[2] CHU Limoges, Dept Physiol, Limoges, France
[3] Laennec Med Sch, Dept Pharmacol, Lyon, France
来源：
JOURNAL OF HYPERTENSION | 2002年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
P607
引用
收藏
页码：S147 / S147
页数：1
相关论文
共 50 条
  • [31] Angiotensin II type 2 receptor vasoactivity in internal mammary arteries of patients with coronary artery disease
    de Wal, R. M. A. van
    van der Harst, P.
    Wagenaar, L. J.
    Wassmann, S.
    Morshuis, W. J.
    Nickenig, G.
    Buikema, H.
    Plokker, H. W. M.
    van Veldhuisen, D. J.
    van Gilst, W. H.
    Voors, A. A.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2007, 50 (04) : 372 - 379
  • [32] Angiotensin II induces endothelial xanthine oxidase activation - Role for endothelial dysfunction in patients with coronary disease
    Landmesser, Ulf
    Spiekermann, Stephan
    Preuss, Christoph
    Sorrentino, Sajoscha
    Fischer, Dieter
    Manes, Costantina
    Mueller, Maja
    Drexler, Helmut
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (04) : 943 - 948
  • [33] Effect of valsartan, an angiotensin II receptor blocker, on postchallenge hyperglycemia and hyperinsulinemia in patients with coronary artery disease
    Koga, S.
    Ikeda, S.
    Yamasa, T.
    Yasunaga, T.
    Nakata, T.
    Kohno, S.
    Maemura, K.
    EUROPEAN HEART JOURNAL, 2009, 30 : 229 - 229
  • [34] EFFECT OF ANGIOTENSIN II RECEPTOR BLOCKERS, CANDESARTAN, ON OSTEOPROTEGERIN LEVEL IN HYPERTENSIVE PATIENTS: LINK BETWEEN BONE AND RAAS
    Shargorodsky, M. S.
    OSTEOPOROSIS INTERNATIONAL, 2015, 26 : S141 - S142
  • [35] Effect of angiotensin II receptor blockers, candesartan, on osteoprotegerin level in hypertensive patients: Link between bone and RAAS
    Oz, H.
    Gavish, D.
    Hass, A.
    Shargorodsky, M.
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2015, 16 (03) : 547 - 552
  • [36] Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and the risk of major adverse cardiac events in patients with diabetes and prior stroke: a nationwide study
    Shih, Chia-Jen
    Chen, Hung-Ta
    Chao, Pei-Wen
    Kuo, Shu-Chen
    Li, Szu-Yuan
    Yang, Chih-Yu
    Tarng, Der-Cherng
    Ou, Shuo-Ming
    Chen, Yung-Tai
    JOURNAL OF HYPERTENSION, 2016, 34 (03) : 567 - 575
  • [37] Lack Of Survival Benefit of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Revascularized Coronary Artery Disease Patients Without History of Myocardial Infarction
    Nishino, Tomohiro
    Furukawa, Yutaka
    Ehara, Natsuhiko
    Kaji, Shuichiro
    Kinoshita, Makoto
    Kim, Kitae
    Kitai, Takeshi
    Yamamuro, Atsushi
    Kobori, Atsushi
    Tani, Tomoko
    Morimoto, Takeshi
    Kita, Toru
    Kimura, Takeshi
    CIRCULATION, 2011, 124 (21)
  • [38] Expression of angiotensin II receptors in human left and right atrial tissue in atrial fibrillation with and without underlying mitral valve disease
    Goette, A
    Lendeckel, U
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (12) : 2363 - 2363
  • [39] Effects of aliskiren on the fibrinolytic system in patients with coronary artery disease receiving angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor blocker
    Ishibashi, Ken
    Kurisu, Satoshi
    Kato, Yasuko
    Mitsuba, Naoya
    Dohi, Yoshihiro
    Nishioka, Kenji
    Kihara, Yasuki
    HEART AND VESSELS, 2013, 28 (01) : 7 - 11
  • [40] Expression of angiotensin II receptors in human left and right atrial tissue in atrial fibrillation with and without underlying mitral valve disease
    Boldt, A
    Wetzel, U
    Welgl, J
    Garbade, J
    Lauschkel, J
    Hindricks, G
    Kottkamp, H
    Gummert, JF
    Dhein, S
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (10) : 1785 - 1792
12345